Jeffs Roger's Form 4 filing
Axsome Therapeutics, Inc. (AXSM) · filed Aug 26, 2025
- Accession no.
- 0001231615-25-000004
- Filed
- Aug 26, 2025
- Trade date
- Aug 22-26, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions. Open-market sales total $4.41M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Jeffs RogerCIK 0001231615 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 22, 2025 | Common Stock | SSaleDisposed | −16,694 | $120.08 | −$2,004,615.52 | 150,974 | Direct | |
| Aug 26, 2025 | Common Stock | SSaleDisposed | −20,000 | $120.03 | −$2,400,600 | 130,974 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.